CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Science To Consumers Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Science To Consumers Inc
20 W. Park Ave., Suite 207
Phone: (516) 350-5569p:516 350-5569 LONG BEACH, NY  11561  United States Ticker: BEUTBEUT
Business Summary
Science to Consumers, Inc. is a development-stage company. The Company is focused on distribution of Argan oil and Argan oil products to stores, spas, massage therapy offices and individuals in Germany. The Company is focused on marketing and selling DermLastyl skin care products. The Company sells approximately six products that are available to be purchased through its Website and wholesale orders. The Company sells various products, which include Dermalastyl Facial Scrub, Dermalastyl Bx Pro, Dermalastyl Bx Elastropin, Dermalastyl-e Intensive Eye Serum, Dermalastyl-m Wrinkle Eye Radicator, Dermalastyl-m Anti- Wrinkle after shave for Men. The Company is focused on marketing its products in China and its activities are divided into two segments, which include China activities and Hong Kong activities. As of May 31, 2016, the Company had not generated any revenues.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/28/20175/31/2016YesYes---

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Financial Officer, Director VitaliyGorelik 39 7/22/2014 4/15/2013
Chief Executive Officer EdwonLam 8/18/2015 8/18/2015

General Information
Outstanding Shares: 31,920,000 (As of 4/10/2017)
Stock Exchange: OTC
Federal Tax Id: 331227949


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023